Compounds > 7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline
Page last updated: 2024-09-03

7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline and Carcinoma, Anaplastic

7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hodgkiss, RJ; Webster, L; Wilson, GD1

Other Studies

1 other study(ies) available for 7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline and Carcinoma, Anaplastic

ArticleYear
Development of bioreductive markers for tumour hypoxia.
    Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:3

    Topics: Animals; Antibodies; Antibodies, Monoclonal; Caffeine; Carcinoma; Cell Division; Cell Hypoxia; Cell Line; DNA, Neoplasm; Mice; Mice, Inbred CBA; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Theophylline; Tumor Cells, Cultured

1995